Weight-loss plateaus: physiology before blame
Review a possible weight-loss plateau with a practical checklist for measurements, appetite, treatment barriers, symptoms, and goals before making changes.
Search explainers, questions, and medicine profiles.
The publication’s independent editorial identity, covering weight-management research, treatments and practical strategies. No individual clinician or professional credential is claimed.
How we workMyWeightLab is an independent, evidence-first publication following GLP-1 medicines, obesity-drug research and the practical science of weight management.
This is a publication byline, not a clinician credential. Our articles do not provide diagnosis, prescriptions or individual treatment advice.
We check regulatory documents, trial registries, prescribing information and peer-reviewed research. Trial design, reported results and marketing approval are separate facts. Sponsor announcements are identified as such.
Editorial source review is distinct from independent clinical review. A real reviewer is credited only when their identity and contribution have been verified.
Review a possible weight-loss plateau with a practical checklist for measurements, appetite, treatment barriers, symptoms, and goals before making changes.
What a 20-person feeding trial found about ultra-processed menus, where its conclusions stop, and how to compare realistic grocery choices.
Tirzepatide’s weight-loss trials, semaglutide comparison, maintenance evidence, sleep-apnoea indication and safety limits, explained.
Read the population, comparator, duration, analysis, and harms before deciding what a weight-loss headline really means.
Read semaglutide’s STEP and SELECT results, product-specific approvals, safety warnings and weight-maintenance evidence.
What the sleep-extension trial means: the 270-calorie comparison, two-week limits, objective intake methods and a practical sleep observation sheet.
Use resistance activity to support daily function while managing weight, with a starting point matched to your ability.
Read survodutide’s SYNCHRONIZE Phase 3 results, gastrointestinal safety findings and separate MASH research with clear evidence limits.
Build a plan around health goals, meals, movement, support, and maintenance instead of a deadline that keeps moving.
Read the 12-month eating-window trial with its actual comparator, weight estimates and uncertainty, then assess practical schedule tradeoffs.